Zentalis Pharmaceuticals, Inc. - Common Stock (ZNTL)

CUSIP: 98943L107

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-219,009
SEC-reported price per share
$2.77
Number of holders
15
Value change
-$1,090,936
Number of buys
8
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
94,436,195

Security key

98943L107

Report period

Q3 2026

Institutions

15

Top holders

10

Ownership snapshot

Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WALTERS GROUP
Disclosed value leader
WALTERS GROUP
Comparable rows
9/15
Latest evidence
14 Aug 2026
13D/G 3/4/5 13F Lead comparable stake: 19% 6 rows are not safely comparable across share classes. 13D/G row: WALTERS GROUP Showing 1-6 of 15 holder rows.

Quick read

WALTERS GROUP leads the comparable SEC ownership view at 19%.

9 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WALTERS GROUP's linked filing trail.
Comparable ownership Top 5
WALTERS GROUP 19%
William Thurman Walters 9.9%
5AM Opportunities II (GP), LLC 6.4%
Squadron Capital Management LLC 5.1%
VANGUARD GROUP INC 4.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WALTERS GROUP
13D/G 3/4/5
Walters William T · 10%+ Owner
19%
Reported 13D/G · 14 Aug 2026
$77,268,733
17,844,973 shares
+$18,770,550 14 Aug 2026
William Thurman Walters
3/4/5 13D/G
10%+ Owner · Walters William T
9.9%
Reported 13D/G · 29 Jan 2025
$62,457,405
17,844,973 shares
+$15,172,500 14 Aug 2026
5AM Opportunities II (GP), LLC
13D/G
Andrew J. Schwab
6.4%
Reported 13D/G · 18 Dec 2025
$7,257,856
4,838,571 shares
$0 18 Dec 2025
Squadron Capital Management LLC
13F 13D/G
Company · Squadron Master Fund LP
5.1%
Reported 13D/G · 24 Feb 2026
$17,945,000
3,700,000 shares
— 30 Jun 2026
VANGUARD GROUP INC
13D/G
The Vanguard Group
4.6%
Reported 13D/G · 31 Dec 2024
$4,677,873
3,271,240 shares
$0 31 Dec 2024
BlackRock, Inc.
13F 13D/G
Company
4.1%
Reported 13D/G · 30 Sep 2026
$18,204,597
3,753,525 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
114,725
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
113
Q3 2026 holders
15
Holder diff
-98
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .